TRPV1 and colitis: McVey et al. have demonstrated that the administration of the endocannabinoid anandamide in the ileum of rats induces ileitis in a TRPV1-dependent manner [58], and a gain of the function mutation of this receptor also enhances susceptibility to experimental colitis [59].